Loading...

Ken Sack, MD

TitleProfessor Emeritus
InstitutionUniversity of California San Francisco
DepartmentMedicine
Address400 Parnassus Avenue
San Francisco CA 94117
Phone415-353-2054
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Tufts UniversityM.D.1968School of Medicine

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Malladi AS, Sack K, Shiboski SC, Shiboski CH, Baer AN, Banushree R, Dong Y, Helin P, Kirkham BW, Li M, Sugai S, Umehara H, Vivino FB, Vollenweider CF, Zhang W, Zhao Y, Greenspan JS, Daniels TE, Criswell LA. Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry. Arthritis Care Res (Hoboken). 2012 Jun; 64(6):911-8. PMID: 22238244; PMCID: PMC3595164.
    2. Sack K. Taking away the diagnosis. Tex Heart Inst J. 2012; 39(1):1. PMID: 22412218; PMCID: PMC3298926.
    3. Sack K. Is glucosamine MSM effective for osteoarthritis? Postgrad Med. 2006 Jul-Aug; 119(2):97-8. PMID: 16961059.
      View in: PubMed
    4. Davis J, Webb A, Lund S, Sack K. Results from an open-label extension study of etanercept in ankylosing spondylitis. Arthritis Rheum. 2004 Apr 15; 51(2):302-4. PMID: 15077279.
      View in: PubMed
    5. Morehead K, Sack K. Osteoarthritis. What therapies for this disease of many causes? Postgrad Med. 2003 Nov; 114(5):11-7. PMID: 14650089.
      View in: PubMed
    6. Gorman JD, Sack K, Davis JC. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med. 2002 May 02; 346(18):1349-56. PMID: 11986408.
      View in: PubMed